A Prospective Randomized Placebo-controlled Study of the Effect of Eplerenone on Left Ventricular Diastolic Function in Women Receiving Anthracycline Therapy for Breast Cancer

Trial Profile

A Prospective Randomized Placebo-controlled Study of the Effect of Eplerenone on Left Ventricular Diastolic Function in Women Receiving Anthracycline Therapy for Breast Cancer

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 09 Jan 2017

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Jan 2017 Status changed from not yet recruiting to discontinued due to Futility.
    • 11 Jun 2014 Planned End Date changed from 1 Oct 2015 to 1 May 2015 as reported by ClinicalTrials.gov.
    • 05 Nov 2013 Company added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top